Cargando…
Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy
Arrhythmogenic cardiomyopathy (ACM), a fatal heart disease characterized by fibroadipocytic replacement of cardiac myocytes, accounts for 20% of sudden cardiac death and lacks effective treatment. It is often caused by mutations in desmosome proteins, with Desmoglein-2 (DSG2) mutations as a common e...
Autores principales: | Lin, Yubi, Liu, Ruonan, Huang, Yanling, Yang, Zhe, Xian, Jianzhong, Huang, Jingmin, Qiu, Zirui, Lin, Xiufang, Zhang, Mengzhen, Chen, Hui, Wang, Huadong, Huang, Jiana, Xu, Geyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939300/ https://www.ncbi.nlm.nih.gov/pubmed/36815030 http://dx.doi.org/10.1016/j.apsb.2022.05.018 |
Ejemplares similares
-
Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
por: Qiu, Zirui, et al.
Publicado: (2022) -
Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation
por: Lin, Yubi, et al.
Publicado: (2021) -
Arrhythmogenic cardiomyopathy related DSG2 mutations affect desmosomal cadherin binding kinetics
por: Dieding, Mareike, et al.
Publicado: (2017) -
Misdiagnosed myocarditis in arrhythmogenic cardiomyopathy induced by a homozygous variant of DSG2: a case report
por: Liu, Xuwei, et al.
Publicado: (2023) -
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2009)